R. Chris Rathbun, Pharm.D., BCPS, AQ-ID

Prof & Chair

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47254

Fax (405) 271-6430

Office CPB 211

Email chris-rathbun@ouhsc.edu

Summary

Research interests are centered in the area of HIV infection and include optimization of antiretroviral therapy, evaluation of novel antiretroviral agents and treatment strategies, medication adherence with antiretroviral regimens, and pharmacokinetic/pharmacodynamics drug interactions among antiretrovirals.


Research

Infectious diseases.



Education & Experience

B.S. in Chemistry

University of Minnesota College of Chemistry, Duluth, MN

Pharm.D. in Pharmacy

University of Minnesota College of Pharmacy, Minneapolis, MN

BCPS in Pharmacotherapy specialist

Board of Pharmaceutical Specialties 1991

AQ-ID in Added qualification in infectious diseases pharmacotherapy

Board of Pharmaceutical Specialties 1999


Publications & Presentations

1 2 3 4 > >>
    1. Rathbun C, Durham S H, Farmer K, Zuckerman A, Badowski M. Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United States. Currents in Pharmacy Teaching and Learning. 2020; 12 : (in press)

    2. Pham T, Rathbun C, Keast S, Nesser N, Farmer K, Skrepnek G H. National estimates of case-mix, mortality, and economic outcomes amoung inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the U.S. Journal Evaluation Clinical Practice. 2019; 25 : 806-821

    3. Pham T T, Keast S, Farmer K, Thompson D M, Rathbun C, Nesser N J, Holderread B P, Skrepnek G H. Sustained virologic response and costs associated with direct-acting antivirals for chronic hepatitis C infection in Oklahoma Medicaid. Journal of Managed Care and Specialty Pharmacy. 2018; 24 : 664-676

    4. Pham T, Rathbun C, Keast S, Nesser N, Farmer K, Skrepnek G H. National estimates of case-mix, mortality, and economic outcomes among inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the US. Journal of Evaluation in Clinical Practice . 2018

    5. Rathbun C, Liedtke M D, Miller M M. Antiretroviral Therapy for HIV Infection. eMedicine/Medscape. 2018

1 2 3 4 > >>



Grants

1 2 3 4 >>
    1. HIV Adherence Services. Start Date: 2022. End Date: 2023.

    2. HIV Adherence Services. State Agency. Start Date: 2021. End Date: 2022.

    3. HIV Adherence Services. State Agency. Start Date: 2020. End Date: 2021.

    4. Clinical Pharmacy Services. HHS. Start Date: 2020. End Date: 2020.

    5. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

1 2 3 4 >>



Awards and Honors

>>
    >>



    Education

                                                                                              1.  Degree: BS. University of Minnesota, Duluth. Date: 2005.  

                                                                                              2.  Degree: Infectious Diseases Fellowship. University of Texas at Austin. Date: 1991.  

                                                                                              3.  Degree: PharmD. University of Minnesota, Mpls-St. Paul. Date: 1989.